The production cost of Tobramycin, an aminoglycoside antibiotic used to treat bacterial infections, involves significant capital and operational expenditures. Manufacturing requires investment in fermentation bioreactors, filtration, purification systems, and quality control laboratories to ensure pharmaceutical-grade purity and potency. The primary cost drivers include raw materials such as *Streptomyces tenebrarius* fermentation media, solvents, and chromatography resins for purification. Additional expenses cover utilities, skilled labor, packaging, transportation, and strict regulatory compliance with Good Manufacturing Practices (GMP). Market factors such as raw material availability, competition from generic alternatives, and global demand from the pharmaceutical sector influence overall production costs. Despite these expenses, Tobramycin remains an essential antibiotic due to its effectiveness against Gram-negative bacterial infections, particularly in respiratory and ophthalmic treatments. URL: https://www.procurementresource.com/production-cost-report-store/tobramycin